0001692830-18-000001.txt : 20180212 0001692830-18-000001.hdr.sgml : 20180212 20180212153023 ACCESSION NUMBER: 0001692830-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180212 DATE AS OF CHANGE: 20180212 EFFECTIVENESS DATE: 20180212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-277219 FILM NUMBER: 18596072 BUSINESS ADDRESS: STREET 1: 1337 3RD AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94122 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 1337 3RD AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94122 D/A 1 primary_doc.xml X0708 D/A LIVE 0001692830 Satsuma Pharmaceuticals, Inc. 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 415-505-0809 DELAWARE None None Corporation true 2016 John Kollins 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Tadayoshi Iwashima 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Executive Officer Rajeev Shah 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Director Heath Lukatch 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Director Thomas King 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Director Michael Riebe 400 Oyster Point Blvd. Suite 221 South San Francisco CA CALIFORNIA 94080 Director Pharmaceuticals Decline to Disclose 06b true 0001692830-16-000001 2016-12-16 true true false 1 12288750 12134401 154349 false 4 0 0 0 false Satsuma Pharmaceuticals, Inc. /s/John Kollins John Kollins President & CEO 2018-02-12